41 related articles for article (PubMed ID: 10545476)
21. Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation.
Luton F; Buferne M; Legendre V; Chauvet E; Boyer C; Schmitt-Verhulst AM
J Immunol; 1997 May; 158(9):4162-70. PubMed ID: 9126976
[TBL] [Abstract][Full Text] [Related]
22. A redundant role of the CD3 gamma-immunoreceptor tyrosine-based activation motif in mature T cell function.
Haks MC; Cordaro TA; van den Brakel JH; Haanen JB; de Vries EF; Borst J; Krimpenfort P; Kruisbeek AM
J Immunol; 2001 Feb; 166(4):2576-88. PubMed ID: 11160319
[TBL] [Abstract][Full Text] [Related]
23. TCR dynamics in human mature T lymphocytes lacking CD3 gamma.
Torres PS; Alcover A; Zapata DA; Arnaud J; Pacheco A; Martín-Fernández JM; Villasevil EM; Sanal O; Regueiro JR
J Immunol; 2003 Jun; 170(12):5947-55. PubMed ID: 12794121
[TBL] [Abstract][Full Text] [Related]
24. Essential and partially overlapping role of CD3gamma and CD3delta for development of alphabeta and gammadelta T lymphocytes.
Wang B; Wang N; Salio M; Sharpe A; Allen D; She J; Terhorst C
J Exp Med; 1998 Oct; 188(7):1375-80. PubMed ID: 9763617
[TBL] [Abstract][Full Text] [Related]
25. Biochemical evidence for the presence of a single CD3delta and CD3gamma chain in the surface T cell receptor/CD3 complex.
Pan Q; Gollapudi AS; Dave VP
J Biol Chem; 2004 Dec; 279(49):51068-74. PubMed ID: 15459203
[TBL] [Abstract][Full Text] [Related]
26. Internalization and intracellular fate of TCR-CD3 complexes.
Alcover A; Alarcón B
Crit Rev Immunol; 2000; 20(4):325-46. PubMed ID: 11100805
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of insulin-dependent diabetes mellitus.
Masteller EL; Bluestone JA
Curr Opin Immunol; 2002 Oct; 14(5):652-9. PubMed ID: 12183168
[TBL] [Abstract][Full Text] [Related]
28. The TCR/CD3 complex in leukemogenesis and as a therapeutic target in T-cell acute lymphoblastic leukemia.
Dos Santos NR; Ghysdael J; Tran Quang C
Adv Biol Regul; 2019 Dec; 74():100638. PubMed ID: 31378701
[TBL] [Abstract][Full Text] [Related]
29. Modulating T Cell Responses by Targeting CD3.
Menon AP; Moreno B; Meraviglia-Crivelli D; Nonatelli F; Villanueva H; Barainka M; Zheleva A; van Santen HM; Pastor F
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831533
[TBL] [Abstract][Full Text] [Related]
30. Antigen-induced TCR-CD3 down-modulation does not require CD3delta or CD3gamma cytoplasmic domains, necessary in response to anti-CD3 antibody.
Legendre V; Guimezanes A; Buferne M; Barad M; Schmitt-Verhulst AM; Boyer C
Int Immunol; 1999 Nov; 11(11):1731-8. PubMed ID: 10545476
[TBL] [Abstract][Full Text] [Related]
31. Some hints concerning the shape of T-cell receptor structures.
Rubin B; Alibaud L; Huchenq-Champagne A; Arnaud J; Toribio ML; Constans J
Scand J Immunol; 2002 Feb; 55(2):111-8. PubMed ID: 11896927
[TBL] [Abstract][Full Text] [Related]
32. [Expression anomalies of the CD3-TCR complex expression and immunodeficiencies].
Le Deist F; de Saint Basile G; Rieux-Laucat F; Hivroz C; Fischer A
Med Sci (Paris); 2007 Feb; 23(2):161-6. PubMed ID: 17291425
[TBL] [Abstract][Full Text] [Related]
33. The structural basis of T-cell receptor (TCR) activation: An enduring enigma.
Mariuzza RA; Agnihotri P; Orban J
J Biol Chem; 2020 Jan; 295(4):914-925. PubMed ID: 31848223
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
